19 June 2013
Keywords: Adventrx. Poloxamer-based therapeutics, M&A, Financing, Exelbine
Article | 10 January 2011
San Diego, USA-based ADVENTRX Pharmaceuticals (NYSE Amex: ANX) says that it has signed a term sheet to acquire a private ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2011
18 June 2013
© 2013 thepharmaletter.com